ENABLING SMART PROCUREMENT

Global Pharmaceutical Drug Development Services Category - Procurement Market Intelligence Report

Single User: Allows a single employee of the organization to access the subscribed reports.

  • Published in: Nov 2017
  • Pages: 88
  • SKU: IRCMSTR14642

Global Pharmaceutical Drug Development Services Category - Procurement Market Intelligence Report

USD1500 USD2500

Single User: Allows a single employee of the organization to access the subscribed reports.

SpendEdge’s procurement intelligence research on the global pharmaceutical drug development services market is an all-inclusive guide enabling procurement professionals to make smart purchasing decisions. This report provides a strategic analysis of the supply markets, factors influencing purchasing decisions, procurement best practices, pricing models, supplier landscape and an analysis of the supplier capability matrix.

Key Features of Report

 

Supply Market Insights
Procurement Best Practices
Cost Saving Opportunities
Pricing Models
Negotiation Strategies
Category Risk Analysis
Key Supplier Analysis
Supplier Capability Matrix

 

Pharmaceutical Drug Development Services - Category Spend Analysis

According to analysts at SpendEdge, majority of the demand for drug development services comes from pharmaceutical and biotechnology companies. This is mainly because these companies are increasingly outsourcing drug development services to CROs to reduce drug development costs amid increasing regulatory stringency and reimbursements. Additionally, lead identification, drug discovery, clinical trial monitoring, and regulatory compliance are the services that will drive the growth of the global pharmaceutical drug development services market.

Pharmaceutical Drug Development Services - Procurement Best Practices

 

One of the procurement best practices for buyers is to collaborate with local CROs if project size is small. There is a trend of long-term strategic partnerships in the industry, and as a result, global CROs allocate their best resources to these strategic alliances. Therefore, if the project size is small, then global CROs may not allocate their best resources to the project. As a result, it is advised that buyers collaborate with local CROs if the project size is small. This will ensure buyers that the best resources of the local CROs work on the project, which can significantly increase the probability of the project's success. Furthermore, local CROs can offer services at a low cost and have a deeper understanding of the local regulatory environment compared with global CROs.

Pharmaceutical Drug Development Services - Procurement Challenges

 

According to this procurement research report, one of the key procurement challenges faced by buyers are the issues in data integration and management. Data integration is a pressing issue for buyers as CROs often use disparate sources and formats that might not be compatible with their systems. For instance, buyers use electronic data capture systems for storing their data; however, CROs may use traditional spreadsheets. As a result, when buyers try to reconcile data from multiple sources with their systems, the variations in data formats often leads to data corruption and loss. This makes it difficult for buyers to identify the focus areas and take measures to advance the drug development process.

To overcome the challenges, buyers must engage with suppliers that store their data using systems and formats that are most widely adopted in the industry.

SpendEdge also offers customization of this report to meet your exact requirements. Please contact us at enquiry@spendedge.com

 

Are you an Enterprise User? Try our annual subscription services offering unlimited access to SpendEdge reports. Click here to register for trial/demo.

Drug development services refer to the range of services provided by the clinical research organizations to pharmaceutical companies which help in the development of drugs. Such services include drug discovery assistance, lead identification, clinical trials, and project management. This upcoming procurement research report, which is part of SpendEdge’s pharma and healthcare category, would provide actionable insights on the market trends and drivers, pricing strategies, procurement challenges and best practices, and the supply landscape for the global pharmaceutical drug development services market.

Category overview of the global pharmaceutical drug development services market

Based on the end-users pharmaceutical drug development services can be categorized into:

  • Pharmaceutical companies
  • Biotechnology companies

Additionally, this report also considers segmentation of the market based on services including clinical trial monitoring, drug discovery and consulting services, regulatory compliance, project management, and data management.

This upcoming procurement research on pharmaceutical drug development services would provide detailed insights into the continuously evolving supplier landscape to help improve source-to-contract cycle performance. Moreover, it would help sourcing professionals develop enhanced category strategies, boost savings, understand supplier and market challenges, and implement sourcing best practices.

Read less

Key Features of Report

 

Supply Market Insights
Procurement Best Practices
Cost Saving Opportunities
Pricing Models
Negotiation Strategies
Category Risk Analysis
Key Supplier Analysis
Supplier Capability Matrix

 

Pharmaceutical Drug Development Services - Category Spend Analysis

According to analysts at SpendEdge, majority of the demand for drug development services comes from pharmaceutical and biotechnology companies. This is mainly because these companies are increasingly outsourcing drug development services to CROs to reduce drug development costs amid increasing regulatory stringency and reimbursements. Additionally, lead identification, drug discovery, clinical trial monitoring, and regulatory compliance are the services that will drive the growth of the global pharmaceutical drug development services market.

Pharmaceutical Drug Development Services - Procurement Best Practices

 

One of the procurement best practices for buyers is to collaborate with local CROs if project size is small. There is a trend of long-term strategic partnerships in the industry, and as a result, global CROs allocate their best resources to these strategic alliances. Therefore, if the project size is small, then global CROs may not allocate their best resources to the project. As a result, it is advised that buyers collaborate with local CROs if the project size is small. This will ensure buyers that the best resources of the local CROs work on the project, which can significantly increase the probability of the project's success. Furthermore, local CROs can offer services at a low cost and have a deeper understanding of the local regulatory environment compared with global CROs.

Pharmaceutical Drug Development Services - Procurement Challenges

 

According to this procurement research report, one of the key procurement challenges faced by buyers are the issues in data integration and management. Data integration is a pressing issue for buyers as CROs often use disparate sources and formats that might not be compatible with their systems. For instance, buyers use electronic data capture systems for storing their data; however, CROs may use traditional spreadsheets. As a result, when buyers try to reconcile data from multiple sources with their systems, the variations in data formats often leads to data corruption and loss. This makes it difficult for buyers to identify the focus areas and take measures to advance the drug development process.

To overcome the challenges, buyers must engage with suppliers that store their data using systems and formats that are most widely adopted in the industry.

SpendEdge also offers customization of this report to meet your exact requirements. Please contact us at enquiry@spendedge.com

 

Are you an Enterprise User? Try our annual subscription services offering unlimited access to SpendEdge reports. Click here to register for trial/demo.

Drug development services refer to the range of services provided by the clinical research organizations to pharmaceutical companies which help in the development of drugs. Such services include drug discovery assistance, lead identification, clinical trials, and project management. This upcoming procurement research report, which is part of SpendEdge’s pharma and healthcare category, would provide actionable insights on the market trends and drivers, pricing strategies, procurement challenges and best practices, and the supply landscape for the global pharmaceutical drug development services market.

Category overview of the global pharmaceutical drug development services market

Based on the end-users pharmaceutical drug development services can be categorized into:

  • Pharmaceutical companies
  • Biotechnology companies

Additionally, this report also considers segmentation of the market based on services including clinical trial monitoring, drug discovery and consulting services, regulatory compliance, project management, and data management.

This upcoming procurement research on pharmaceutical drug development services would provide detailed insights into the continuously evolving supplier landscape to help improve source-to-contract cycle performance. Moreover, it would help sourcing professionals develop enhanced category strategies, boost savings, understand supplier and market challenges, and implement sourcing best practices.

PART 1: CATEGORY AT A GLANCE

  • TAKEAWAY 01 | Market Overview
  • TAKEAWAY 02 | Demand and Supply Snapshot
  • TAKEAWAY 03 | Key Market Dynamics
  • TAKEAWAY 04 | Supply Market Highlights
  • TAKEAWAY 05 | Pricing Insights
  • TAKEAWAY 06 | Procurement Insights

PART 2:  SCOPE OF THE REPORT

  • Category Definition
  • Research Methodology

PART 3: MARKET INSIGHTS

  • Category Spend Analysis
  • Category Maturity by Regions
  • Demand-Supply Shifts
  • Regional Demand-Supply Snapshot
  • Market Developments
  • Regional Impact of Trends
  • Key Category Growth Drivers and Corresponding Regional Impacts
  • Major Category Growth Constraints and Corresponding Regional Impacts
  • Key Current Technological Innovations
  • Major Regulatory Frameworks
  • Strategic Sustainability Practices
  • Porter’s Five Forces
  • PESTLE Analysis

PART 4: SUPPLY MARKET INSIGHTS

  • Supplier Operational Capability Matrix
  • Other Prominent Suppliers by Region: Operational Capability Matrix
  • Supplier Functional Capability Matrix
  • Other Prominent Suppliers by Region: Functional Capability Matrix
  • Key Clients/Partners
  • Supplier Cost Breakup
  • Supplier Positioning Matrix

PART 5: PRICING INSIGHTS

  • Pricing Models Snapshot
  • Pricing Models – Pros and Cons
  • Indicative Pricing

PART 6: PROCUREMENT INSIGHTS

  • Major Category Requirements
  • Major Procurement Pain Points
  • Category Sourcing Evolution Matrix
  • Procurement Best Practices
  • Cost-saving Opportunities
  • Supplier Selection Criteria
  • Category Negotiation Strategies
  • SLA Terms
  • Supplier Evaluation Criteria
  • Category Risk Analysis

PART 7: TOP FIVE SUPPLIERS

  • IQVIA
  • LabCorp
  • PAREXEL
  • ICON
  • INC Research

PART 8: APPENDIX

  • Glossary
  • Key Notes
  • About Us
Read less

PART 1: CATEGORY AT A GLANCE

  • TAKEAWAY 01 | Market Overview
  • TAKEAWAY 02 | Demand and Supply Snapshot
  • TAKEAWAY 03 | Key Market Dynamics
  • TAKEAWAY 04 | Supply Market Highlights
  • TAKEAWAY 05 | Pricing Insights
  • TAKEAWAY 06 | Procurement Insights

PART 2:  SCOPE OF THE REPORT

  • Category Definition
  • Research Methodology

PART 3: MARKET INSIGHTS

  • Category Spend Analysis
  • Category Maturity by Regions
  • Demand-Supply Shifts
  • Regional Demand-Supply Snapshot
  • Market Developments
  • Regional Impact of Trends
  • Key Category Growth Drivers and Corresponding Regional Impacts
  • Major Category Growth Constraints and Corresponding Regional Impacts
  • Key Current Technological Innovations
  • Major Regulatory Frameworks
  • Strategic Sustainability Practices
  • Porter’s Five Forces
  • PESTLE Analysis

PART 4: SUPPLY MARKET INSIGHTS

  • Supplier Operational Capability Matrix
  • Other Prominent Suppliers by Region: Operational Capability Matrix
  • Supplier Functional Capability Matrix
  • Other Prominent Suppliers by Region: Functional Capability Matrix
  • Key Clients/Partners
  • Supplier Cost Breakup
  • Supplier Positioning Matrix

PART 5: PRICING INSIGHTS

  • Pricing Models Snapshot
  • Pricing Models – Pros and Cons
  • Indicative Pricing

PART 6: PROCUREMENT INSIGHTS

  • Major Category Requirements
  • Major Procurement Pain Points
  • Category Sourcing Evolution Matrix
  • Procurement Best Practices
  • Cost-saving Opportunities
  • Supplier Selection Criteria
  • Category Negotiation Strategies
  • SLA Terms
  • Supplier Evaluation Criteria
  • Category Risk Analysis

PART 7: TOP FIVE SUPPLIERS

  • IQVIA
  • LabCorp
  • PAREXEL
  • ICON
  • INC Research

PART 8: APPENDIX

  • Glossary
  • Key Notes
  • About Us

Stay connected with us